Bittner, B., Locke, K. W., Maneval, D. C., Flamion, B., Connor, R. J., Kang, D. W., & Tannenbaum, R. (2022). ENHANZE® drug delivery technology: Advancing subcutaneous drug delivery using recombinant human hyaluronidase PH20. UK: Karger.
Citación estilo ChicagoBittner, Beate, Kenneth W. Locke, Daniel C. Maneval, Bruno Flamion, Robert J. Connor, David W. Kang, y Renee Tannenbaum. ENHANZE® Drug Delivery Technology: Advancing Subcutaneous Drug Delivery Using Recombinant Human Hyaluronidase PH20. UK: Karger, 2022.
Cita MLABittner, Beate, et al. ENHANZE® Drug Delivery Technology: Advancing Subcutaneous Drug Delivery Using Recombinant Human Hyaluronidase PH20. UK: Karger, 2022.
Precaución: Estas citas no son 100% exactas.